Test Price
320 AED✅ Home Collection Available
Galactosemia Panel 1 Test in UAE | 320 AED | DHA Licensed
Executive Summary & Core Metrics
This diagnostic panel, offered exclusively through DNA Labs UAE (DHA Facility License: 1143), delivers 99.9% diagnostic sensitivity for the detection of classic and variant galactosemia via ISO 9001:2015 accredited processing.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Galactosemia Panel 1 is a targeted qualitative enzyme spot test that simultaneously assesses galactose-1-phosphate uridyltransferase (GALT), galactokinase (GALK), and UDP-galactose-4-epimerase (GALE) activities in whole blood — the core biochemical defect in classic and variant galactosemias.
| Parameter | This Lab (DNA Labs UAE) | Alternative (Standard Hospital Lab) |
|---|---|---|
| Methodology | Qualitative Enzyme Spot Test (GALT/GALK/GALE) – ISO-standardised | Quantitative fluorometric assay (longer TAT, higher cost) |
| Diagnostic Precision | 99.9% sensitivity; same-day run, 5-day report | Varies; often >10 days for full panel |
| Sample Stability & Logistics | Refrigerated cold-chain; strict 60-day post-transfusion exclusion | Frozen samples occasionally accepted, risking enzyme denaturation |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics | DHA Registration ID: 9294403): “A negative spot test in a symptomatic infant does not entirely exclude variant galactosemia; clinical correlation supplemented by quantitative enzymatic or molecular analysis is advisable. A confirmed positive result necessitates immediate specialist dietary intervention, as unmanaged galactosemia poses risks of irreversible neurological and hepatic impairment.”
Clinical Advisory & Medication Guidance
⚠️ Important Clinical Advisory
Do not modify or discontinue any prescribed dietary restrictions (e.g., galactose-free diet) or medications without direct consultation with your managing physician. Abrupt dietary changes in confirmed galactosemia can precipitate a metabolic crisis.
Exclusion Criteria & Emergency Red Flags
- Sample Rejection: Collection within 60 days of blood transfusion; hemolyzed or frozen specimens; missing clinical or drug history.
- Patient Red Flags (seek urgent medical care): New-onset lethargy, persistent vomiting, jaundice, sepsis-like appearance in neonates, unexplained hepatic dysfunction, or failure to thrive.
- Drug Interference: Certain antibiotics and anticonvulsants may transiently alter enzyme readings – disclose all medications during sample collection.
Patient FAQ & Clinical Guidance
1. What exactly does the Galactosemia Panel 1 measure?
It qualitatively detects the activities of three key enzymes – GALT, GALK, and GALE – that break down galactose, thereby confirming or excluding classic and variant galactosemia. This test is pivotal for the early diagnosis of inborn errors of metabolism.
2. How should I prepare my child for this test?
No fasting is required, but the sample must be collected at least 60 days after any blood transfusion. A complete medication list must accompany the sample to avoid false interpretations.
3. How quickly will I receive results, and what do they mean?
Reports are delivered within 5 days of sample collection. A normal result indicates absent or minimal enzyme defect, while a positive result necessitates urgent metabolic consultation to initiate dietary management.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to the UAE's legislative framework for health data and personal privacy. All diagnostic processes and data handling protocols comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability, governing patient safety and informed consent.
DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Galactosemia Panel 1 |
| Price (AED) | 320 AED |
| Turnaround Time | 5 Days |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Qualitative Enzyme Spot Test (GALT/GALK/GALE) |
| ICD-10-CM Code | E74.21 |
| LOINC Code | 97695-6 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians